BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32772456)

  • 21. Lack of evidence for a reciprocal interaction between bacterial and cytomegalovirus infection in the allogeneic stem cell transplantation setting.
    Vinuesa V; Solano C; Giménez E; Piñana JL; Boluda JC; Amat P; Navarro D
    Transpl Int; 2016 Nov; 29(11):1196-1204. PubMed ID: 27529151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cytomegalovirus infection monitoring in patients with long-term survival after allogeneic hematopoietic stem cell transplantation].
    Chen L; Luo Y; Hu Y; Tan Y; Zhao Y; Fan J; Huang H
    Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(40):3145-9. PubMed ID: 25573309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
    Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relationship between copies of cytomegalovirus in plasma and cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation].
    Chen YH; Zhao XS; Liu KY; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang Y; Zhao T; Zhao XT; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1540-3. PubMed ID: 19953881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for cytomegalovirus DNAemia following haploidentical stem cell transplantation and its association with host hepatitis B virus serostatus.
    Chen Y; Xu LP; Liu KY; Chen H; Chen YH; Zhang XH; Wang Y; Wang FR; Han W; Wang JZ; Yan CH; Huang XJ
    J Clin Virol; 2016 Feb; 75():10-5. PubMed ID: 26735213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Sirolimus Exposure on the Need for Preemptive Antiviral Therapy for Cytomeglovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
    Guglieri-Lopez B; Perez-Pitarch A; Garcia-Cadenas I; Gimenez E; Barba P; Rabella N; Hernandez-Boluda JC; Fox L; Valcarcel D; Esquirol A; Ferriols-Lisart R; Sierra J; Solano C; Navarro D; Martino R; Piñana JL
    Biol Blood Marrow Transplant; 2019 May; 25(5):1022-1030. PubMed ID: 30639821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of virus population diversity on the dynamics of cytomegalovirus DNAemia in allogeneic stem cell transplant recipients.
    Vinuesa V; Bracho MA; Albert E; Solano C; Torres-Puente M; Giménez E; González-Candelas F; Navarro D
    J Gen Virol; 2017 Oct; 98(10):2530-2542. PubMed ID: 28874227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-engraftment cytomegalovirus DNAemia in allogeneic hematopoietic stem cell transplant recipients: incidence, risk factors, and clinical outcomes.
    Solano C; Giménez E; Albert E; Mateo EM; Gómez M; Goterris R; Pérez A; Amat P; Hernández-Boluda JC; Poch M; Piñana JL; Navarro D
    Bone Marrow Transplant; 2019 Jan; 54(1):90-98. PubMed ID: 29899574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
    Albert E; Solano C; Giménez E; Focosi D; Pérez A; Macera L; Piñana JL; Boluda JCH; Maggi F; Navarro D
    Bone Marrow Transplant; 2018 Feb; 53(2):180-187. PubMed ID: 29084205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics and viral load patterns in children with cytomegalovirus gastrointestinal disease after allogeneic hematopoietic stem cell transplantation.
    Kang HM; Kim SK; Ryu IH; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B
    Bone Marrow Transplant; 2021 Nov; 56(11):2813-2819. PubMed ID: 34274956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical Study of Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation].
    Xiong YY; Liu L; Chen JB; Tang XQ; Xiao Q; Zhang HB; Wang L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):513-521. PubMed ID: 37096528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of cytomegalovirus DNAemia on overall and non-relapse mortality in allogeneic stem cell transplant recipients.
    Solano C; Giménez E; Piñana JL; Albert E; Vinuesa V; Hernández-Boluda JC; Amat P; Navarro D
    Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28471073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
    Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C
    Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in cytomegalovirus plasma viral loads measured in allogeneic hematopoietic stem cell transplant recipients using two commercial real-time PCR assays.
    Gracia-Ahufinger I; Tormo N; Espigado I; Solano C; Urbano-Ispizua A; Clari MA; de la Cruz-Vicente F; Navarro D; Pérez-Romero P
    J Clin Virol; 2010 Jun; 48(2):142-6. PubMed ID: 20395168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical Analysis of Cytomegalovirus Infection after Different Patterns of Hematopoietic Stem Cell Transplantation].
    Wang S; Liu DB; Zheng XL; Ding L; Han DM; Wang ZD; Yan HM; Wang HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1438-44. PubMed ID: 26524053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytomegalovirus Reactivation Is Associated with Increased Risk of Late-Onset Invasive Fungal Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Study in the Current Era of Viral Load Monitoring.
    Yong MK; Ananda-Rajah M; Cameron PU; Morrissey CO; Spencer A; Ritchie D; Cheng AC; Lewin SR; Slavin M
    Biol Blood Marrow Transplant; 2017 Nov; 23(11):1961-1967. PubMed ID: 28797778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridioides difficile Infection and Risk of Acute Graft-versus-Host Disease among Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Jabr R; El Atrouni W; Shune L; Telfah M; Gao G; He J; Abhyankar S; McGuirk J; Clough L
    Transplant Cell Ther; 2021 Feb; 27(2):176.e1-176.e8. PubMed ID: 33830032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease.
    Cantoni N; Hirsch HH; Khanna N; Gerull S; Buser A; Bucher C; Halter J; Heim D; Tichelli A; Gratwohl A; Stern M
    Biol Blood Marrow Transplant; 2010 Sep; 16(9):1309-14. PubMed ID: 20353832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytomegalovirus DNAemia and treatment following allogeneic stem cell transplantation with a focus on long-term outcome.
    Lindahl JK; Woxenius S; Brune M; Andersson R
    Scand J Infect Dis; 2010 Sep; 42(9):691-8. PubMed ID: 20429709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sirolimus exposure and the occurrence of cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation.
    Piñana JL; Perez-Pitarch A; Guglieri-Lopez B; Giménez E; Hernandez-Boluda JC; Terol MJ; Ferriols-Lisart R; Solano C; Navarro D
    Am J Transplant; 2018 Dec; 18(12):2885-2894. PubMed ID: 29603596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.